Impact of the Latest Clinical Data among Patients with Breast Cancer in Low- and Middle-Income Countries

Shaheenah Dawood; A F M Kamal Uddin; Sewanti Limaye

doi:10.1159/000527987

Impact of the Latest Clinical Data among Patients with Breast Cancer in Low- and Middle-Income Countries

Breast Care (Basel). 2022 Dec;17(6):580-585. doi: 10.1159/000527987. Epub 2022 Nov 9.

Authors

Shaheenah Dawood¹, A F M Kamal Uddin², Sewanti Limaye³

Affiliations

¹ Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
² Department of Radiation Oncology at the National Institute of ENT, Dhaka, Bangladesh.
³ Division of Medical and Precision Oncology, Sir H.N. Reliance Foundation Hospital and Research Centre, Mumbai, India.

No abstract available

Keywords: ASCO; Denosumab; Palbociclib; Pembrolizumab; Sacituzumab; Trastuzumab.

Grants and funding

Dr. Shaheenah Dawood received research funding from MSD, Amgen, and the Al Jalila Foundation. Dr. A.F.M. Kamal Uddin and Dr. Sewanti Limaye have no funding sources to declare.